Psychiatry Recommendations
To view Article Recommendations, you must have an active subscription.
If your access has expired, you can subscribe at $9.95 per month, the first month of your subscription will be free of charge.
If you think you should be able to access this content, please contact us.
Sign in | Subscribe | Recommend to Library
New to F1000? See this week’s top article below for a free preview of a Recommendation.
HEADS OF FACULTY
-
School of Medicine, University of Brussels, Dworp-Beersel, Belgium
-
Child Psychiatry Branch, National Institute of Mental Health, Bethesda, MD, USA
LATEST RECOMMENDATION
TOP RATED ARTICLE THIS WEEK [FREE TO VIEW]
2 Recommendations, most recent by
David Castle, University of Melbourne, Australia. F1000 Pharmacology & Drug Discovery
- Clinical Trial
- Clinical Trial: RCT
- Confirmation
- Good for Teaching
- Interesting Hypothesis
- New Finding
- Novel Drug Target
Past 7 Days
20
New Recommendations
6,087 total
12
New Articles Recommended
3,808 total
Past 30 Days
-
23Articles Classified As Good for Teaching143 total
-
7Articles Classified As Review / Commentary386 total
-
8Articles Classified As Controversial376 total
-
2Articles Classified As Technical Advance249 total
-
28Articles Classified As Confirmation1,371 total
-
5Articles Classified As Novel Drug Target77 total
-
35Articles Classified As Clinical Trial1,241 total
-
12Articles Classified As Interesting Hypothesis751 total
-
61Articles Classified As New Finding3,498 total
INDIVIDUAL SUBSCRIPTIONS
Get instant access to Article Recommendations from more than 5,000 expert scientists and clinical researchers, assisted by 5,000 associates, by taking out a monthly subscription. The first month of your subscription will be free of charge.
Start your personal subscription today.
Subscribe for $9.95/monthINSTITUTIONAL SUBSCRIPTIONS
Send a recommendation to your institution's librarian or information manager to request an extended free trial for all users.
Recommend to your LibrarianIf you are a librarian or information manager, you may request an extended free trial for your academic or corporate institution.
Request an Institutional Trialyour institution might be eligible for free access via our sponsorship scheme. Check our sponsorship page.
